Abstract
The year 2014 produced several noteworthy articles that have advanced the care of thoracic surgery patients. Further knowledge has been gained regarding screening and treatment of early stage lung cancer. The use of neoadjuvant therapy for subsets of patients with esophageal cancer continues to evolve. Endobronchial therapy for emphysema is reported in a multicenter trial. The purpose of this review is to highlight the major advances in thoracic surgical disease in the year 2014.
Keywords
Get full access to this article
View all access options for this article.
